Snapshot from Jun 08, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Technology / Apollo Hospitals launches CERAMENT G in India
Tech product launch

Apollo Hospitals launches CERAMENT G in India

Analysis based on 6 articles · First reported May 05, 2026 · Last updated May 07, 2026

Sentiment
60
Attention
3
Articles
6
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The introduction of CERAMENT G by Apollo Hospitals in India is expected to positively impact the healthcare sector, particularly in diabetes care and orthopaedics. This innovation could lead to improved patient outcomes and potentially reduce healthcare costs associated with amputations, benefiting Apollo Hospitals' market position and BONESUPPORT AB's global sales.

Healthcare Biotechnology Medical Devices
Event Summary

Apollo Hospitals has launched an advanced bone regeneration and infection management solution, CERAMENT G, in India, developed by BONESUPPORT AB. This solution aims to address the high incidence of diabetic foot complications and complex bone infections in India, a country with over 89 million people living with diabetes. The new single-stage treatment approach is designed to reduce amputations, enable faster bone healing, minimize repeat surgeries, and improve long-term mobility and quality of life for patients. Apollo Hospitals conducted a clinical training program led by Prof. Venu Kavarthapu to ensure effective implementation of this technology. Dr Sangita Reddy of Apollo Hospitals highlighted the solution's potential to significantly improve limb preservation.

Key Actions
100 Apollo Hospitals introduced solution India
80 BONESUPPORT AB developed CERAMENT G
70 Apollo Hospitals conducted training program
Entities Involved
stock
Apollo Hospitals
Apollo Hospitals introduced an advanced bone regeneration and infection management solution in India, aiming to reduce amputations and improve recovery for diabetic foot complications. This enhances its position as a leading healthcare provider.
Importance 100 Sentiment 70
stock
BONESUPPORT AB
BONESUPPORT AB developed CERAMENT G, the advanced bone graft substitute introduced by Apollo Hospitals in India, marking a significant expansion of its product's commercial availability.
Importance 90 Sentiment 70
cnt
India
India is the target market for the new bone regeneration solution, addressing a significant healthcare burden of diabetic foot complications among its 89 million diabetic population.
Importance 80 Sentiment 50
oth
CERAMENT G
CERAMENT G is the injectable, antibiotic-eluting bone graft substitute developed by BONESUPPORT AB and introduced by Apollo Hospitals in India to treat bone infections and aid regeneration.
Importance 80 Sentiment 60
per
Venu Kavarthapu
Venu Kavarthapu, a consultant orthopaedic surgeon, led the clinical training program for Apollo Hospitals' teams on the new bone regeneration solution.
Importance 40 Sentiment 50
per
Sangita Reddy
Sangita Reddy, Joint Managing Director of Apollo Hospitals, emphasized the importance of this innovation in improving patient outcomes and limb preservation.
Importance 40 Sentiment 50
per
Fergus Macleod
Fergus Macleod, General Manager & EVP Europe and Rest of World for BONESUPPORT AB, expressed pleasure in collaborating with Apollo Hospitals to bring CERAMENT G to India.
Importance 30 Sentiment 50
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.